![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA
William Harvey Research Institute, London, United Kingdom (P.U., G.R., D.C., M.P.); and Vascular Biology Unit, Department of Surgical Research, Northwick Park Institute for Medical Research Harrow, Middlesex, United Kingdom (R.M.)
Carbon monoxide (CO) generated by the enzyme heme oxygenase during the breakdown of heme is known to mediate a number of biological effects. Here, we investigated whether CO liberated from a water-soluble CO-releasing molecule (CO-RM) is capable of modulating leukocyte-endothelial interactions. Tricarbonylchoro(glycinato)ruthenium (II) (CORM-3), a fast CO releaser, proved to be anti-inflammatory in two distinct models of acute inflammation in vivo. In both cases, a significant reduction in neutrophil extravasation was observed. Subsequent in vitro static experiments showed that CORM-3 produced a direct effect on neutrophil (polymorphonuclear neutrophil; PMN) adhesion molecule expression; dose-dependently inhibiting platelet-activating factor stimulated CD11b up-regulation and L-selectin shedding, whereas no effect was observed on up-regulation of human umbilical vein endothelial cell (HUVEC) adhesion molecules intercellular adhesion molecule-1 or E-selectin nor on interleukin-8 chemokine production. In addition, when PMN interaction with HUVECs was studied, an inhibitory effect of CORM-3 on cell capture and rolling was observed. The effect of CORM-3 on PMN CD11b expression was mimicked by the incubation of PMN with the selective large potassium channel opener 1,3-dihydro-1-(2-hydroxy-5-(trifluoromethyl)-phenyl)-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619), which suggests that CORM-3 actions in this instance are mediated, at least in part, via opening of this channel. In conclusion, we have reported that CORM-3 possesses acute anti-inflammatory effects in vivo and that these are probably the result of targeting PMN activation and rolling upon the endothelium.
Address correspondence to: Dr. Mauro Perretti, William Harvey Research Institute, Barts and The London, Charterhouse Square, London EC1M 6BQ, UK. E-mail: m.perretti{at}qmul.ac.uk
This article has been cited by other articles:
![]() |
L. Zheng, Z. Zhou, L. Lin, S. Alber, S. Watkins, N. Kaminski, A. M. K. Choi, and D. Morse Carbon Monoxide Modulates {alpha}-Smooth Muscle Actin and Small Proline Rich-1a Expression in Fibrosis Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 85 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
O De Backer, E Elinck, B Blanckaert, L Leybaert, R Motterlini, and R A Lefebvre Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress Gut, March 1, 2009; 58(3): 347 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M L Ferrandiz, N Maicas, I Garcia-Arnandis, M C Terencio, R Motterlini, I Devesa, L A B Joosten, W B van den Berg, and M J Alcaraz Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis Ann Rheum Dis, September 1, 2008; 67(9): 1211 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Guillen, J. Megias, V. Clerigues, F. Gomar, and M. J. Alcaraz The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes Rheumatology, September 1, 2008; 47(9): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Megias, M. I. Guillen, A. Bru, F. Gomar, and M. J. Alcaraz The Carbon Monoxide-Releasing Molecule Tricarbonyldichlororuthenium(II) Dimer Protects Human Osteoarthritic Chondrocytes and Cartilage from the Catabolic Actions of Interleukin-1{beta} J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 56 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Morse and A. M. K. Choi Inhaled CO in the treatment of acute lung injury Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L642 - L643. [Full Text] [PDF] |
||||
![]() |
G. Cepinskas, K. Katada, A. Bihari, and R. F. Potter Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G184 - G191. [Abstract] [Full Text] [PDF] |
||||